文献速递产科母胎医学

妊娠20周前1级高血压与产后不良结局的相关性

Stage 1 hypertension before 20 weeks' gestation and associated postpartum adverse outcomes.
PubMed 文献 · Am J Obstet Gynecol MFM · 2026-03-27

本研究为回顾性队列的二次分析,纳入2014至2016年间在三级中心分娩单胎且孕20周前无慢性高血压的患者。孕20周前1级高血压组产后6周使用降压药的比例显著高于正常血压组(8.8% vs 2.9%,aOR 2.23,95%CI 1.41-3.54),且产后因高血压疾病再入院风险亦升高(aOR 2.11,95%CI 1.10-4.06)。

要点

  • 孕20周前1级高血压增加妊娠期高血压疾病风险(43.0% vs 23.8%)。
  • 该组产后6周持续使用降压药风险升高(aOR 2.23)。
  • 产后因高血压疾病再入院风险亦升高(aOR 2.11)。

核心结论

  • 孕20周前1级高血压是妊娠期高血压疾病、产后6周持续使用降压药及产后因高血压再入院的危险因素,提示需密切产后监测。

研究设计与样本

  • 回顾性队列研究的二次分析,纳入2014年1月1日至2016年6月8日在三级中心分娩单胎且孕20周后分娩的患者,排除孕20周前最高血压≥140/90 mm Hg的慢性高血压及无产后6周数据者。

主要发现

  • 465例(23.1%)符合孕20周前1级高血压标准,1546例孕20周前血压正常(最高血压<130/80 mm Hg)。
  • 1级高血压组较正常血压组年龄更高(28.2±5.7 vs 29.1±5.6岁,P=.002)、肥胖率更高(25.0% vs 52.0%,P<.001)、孕前糖尿病率更高(2.4% vs 5.2%,P=.002)。
  • 1级高血压组妊娠期高血压疾病发生率高于正常血压组(43.0% vs 23.8%,P<.001)。
  • 1级高血压组产后6周使用降压药比例高于正常血压组(8.8% vs 2.9%,aOR 2.23,95%CI 1.41-3.54),仅在妊娠期高血压疾病患者中分析亦显著(P=.02)。
  • 1级高血压组产后因高血压疾病再入院比例高于正常血压组(3.9% vs 1.5%,aOR 2.11,95%CI 1.10-4.06)。

关键数值与推荐

  • 1级高血压定义:收缩压130-139 mm Hg和/或舒张压80-89 mm Hg(美国心脏协会标准)。
  • 慢性高血压定义:孕20周前最高血压≥140/90 mm Hg。
  • 正常血压定义:孕20周前最高血压<130/80 mm Hg。

临床怎么用

  • 对孕20周前诊断为1级高血压的患者,应加强产后血压监测及随访,警惕持续降压治疗需求及产后再入院风险。

局限性

  • 本研究为单中心回顾性队列的二次分析,可能存在残余混杂,且结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Stage 1 hypertension, defined by the American Heart Association as a systolic blood pressure of 130 to 139 mm Hg and/or a diastolic blood pressure of 80 to 89 mm Hg, is associated with an increased risk of developing hypertensive disorders of pregnancy. However, the postpartum implications of this diagnosis remain unknown. OBJECTIVE: This study aimed to evaluate whether stage 1 hypertension before 20 weeks of gestation is associated with persistent antihypertensive medication use at 6 weeks after delivery. STUDY DESIGN: This was a secondary analysis of a retrospective cohort study of all patients who delivered singleton pregnancies after 20 weeks of gestation at a tertiary care center between January 1, 2014, and June 8, 2016. Patients with a diagnosis of chronic hypertension, defined as a maximum blood pressure of ≥140/90 mm Hg before 20 weeks of gestation, and those without 6-week postpartum data were excluded. The primary outcome was antihypertensive medication use at 6 weeks after delivery, which was compared between patients with stage 1 hypertension before 20 weeks of gestation and those with normal blood pressure before 20 weeks of gestation. The secondary outcomes included the development of a hypertensive disorder of pregnancy, antihypertensive medication use at delivery discharge, postpartum readmission for hypertensive disorders of pregnancy, and blood pressure values at 6 weeks after delivery. Multivariate logistic regression was used to adjust for potential cofounders. A sensitivity analysis compared the primary outcome between the groups only among those with hypertensive disorders of pregnancy. RESULTS: Of note, 465 patients (23.1%) met the criteria for stage 1 hypertension before 20 weeks of gestation. The remaining 1546 patients in the cohort were normotensive before 20 weeks of gestation, with a maximum blood pressure of <130/80 mm Hg. Compared with the group with normal blood pressure, the group with stage 1 hypertension had a higher mean age (28.2±5.7 vs 29.1±5.6 years, respectively; P=.002) and higher rates of obesity (25.0% vs 52.0%, respectively; P<.001) and pregestational diabetes mellitus (2.4% vs 5.2%, respectively; P=.002). In addition, patients with stage 1 hypertension were more likely to have a hypertensive disorder of pregnancy in the current pregnancy than those with normal blood pressure (43.0% vs 23.8%, respectively; P<.001). Patients with stage 1 hypertension were significantly more likely to require antihypertensive medication use at 6 weeks after delivery than those with normal blood pressure (8.8% vs 2.9%, respectively; aOR, 2.23 [95% CI, 1.41-3.54]), even when the analysis was restricted to those diagnosed with a hypertensive disorder of pregnancy (P=.02). In addition, patients with stage 1 hypertension were more likely to be readmitted after delivery for a hypertensive disorder of pregnancy than those with normal blood pressure (3.9% vs 1.5%; aOR, 2.11 [95% CI, 1.10-4.06]). CONCLUSION: Stage 1 hypertension before 20 weeks of gestation is a risk factor for hypertensive disorders of pregnancy, persistent antihypertensive medication use at 6 weeks after delivery, and postpartum readmission for hypertension, suggesting that close postpartum surveillance is needed in this patient population. El resumen está disponible en Español al final del artículo.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Chaffay J, Burd J, Goodman B, et al. Stage 1 hypertension before 20 weeks' gestation and associated postpartum adverse outcomes. Am J Obstet Gynecol MFM. 2026. PMID: 41905559. doi:10.1016/j.ajogmf.2026.101948

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。